卫星质体GPR37L1调节了用于疼痛控制的马雷素和通道信号
bioRxiv : the preprint server for biology
|December 18, 2023
概括
在背部根腺卫星质细胞中的G蛋白结合受体37样1 (GPR37L1) 调节神经病痛. 它的配体马瑞辛1为神经病变和疼痛控制提供了一个新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- G蛋白结合受体 37-like 1 (GPR37L1),一个孤儿受体,具有未知的功能,但在背部根质 (DRGs) 中高度表达.
- 由于糖尿病或化疗引起的外围神经病变会降低DRG中的GPR37L1的调节,这表明它在疼痛信号传递中发挥了作用.
研究的目的:
- 研究GPR37L1在神经病痛中的作用及其潜在机制.
- 在SGC中识别GPR37L1的配体和信号通路.
主要方法:
- 从健康和神经病患者模型中分析DRG中的GPR37L1表达.
- 产生和分析GPR37L1淘汰和过度表达的小鼠.
- 研究GPR37L1与SGC中的通道相互作用.
- 使用生物化学测试识别GPR37L1配体.
主要成果:
- 在神经病痛模型中,GPR37L1的表达是下调的.
- 缺乏GPR37L1会加剧神经病痛,而过度表达会减轻神经病痛.
- 在SGC中,GPR37L1调节KCNJ10和KCNJ3通道.
- 马雷辛1 (MaR1) 被确定为一种GPR37L1配体,增强的流入,并防止化疗引起的SGC功能障碍.
- 一种GPR37L1变种 (E296K) 与慢性疼痛风险增加有关.
结论:
- 在SGC中的GPR37L1在调节神经病痛方面发挥着至关重要的作用.
- GPR37L1-MaR1-SGC通道轴代表了神经病变和疼痛管理的新型治疗标.
- 了解与GPR37L1的特定物种通道相互作用对于开发向疗法至关重要.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K
Analgesia and Pain Management
628
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628


